Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2
Abstract Rett syndrome (RTT) is a progressive neurodevelopmental disorder, mainly caused by mutations in MeCP2 and currently with no cure. We report here that neurons from R106W MeCP2 RTT human iPSCs as well as human embryonic stem cells after MeCP2 knockdown exhibit consistent and long-lasting impa...
Prif Awduron: | Xiaoying Chen, Xu Han, Bruno Blanchi, Wuqiang Guan, Weihong Ge, Yong-Chun Yu, Yi E. Sun |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Oxford University Press
2020-08-01
|
Cyfres: | Protein & Cell |
Pynciau: | |
Mynediad Ar-lein: | https://doi.org/10.1007/s13238-020-00773-z |
Eitemau Tebyg
-
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
gan: Ryo Takeguchi, et al.
Cyhoeddwyd: (2020-02-01) -
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
gan: Osman Sharifi, et al.
Cyhoeddwyd: (2021-04-01) -
MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome
gan: Xu-Rui Jin, et al.
Cyhoeddwyd: (2017-10-01) -
Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice
gan: Laura Dean Heckman, et al.
Cyhoeddwyd: (2014-06-01) -
Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders
gan: Xiangling Meng, et al.
Cyhoeddwyd: (2016-06-01)